
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
CluePoints has partnered with ZS to offer capabilities in portfolio-level performance oversight. The new partnership pairs a solutions company focused on study-level risk-based management with a pharmaceutical and biotech solutions provider with capabilities in portfolio-level quality and operational oversight. The partnership also offers consulting from a wider pool of subject matter experts.






